Latest Expert Opinions

Signal
Opinion
Expert
TOP PICK
TOP PICK
August 19, 2009
At a historical discount relative to underlying net asset value, which includes Loblaws (L-T) and a net cash position coming from various different US businesses that they have sold.
At a historical discount relative to underlying net asset value, which includes Loblaws (L-T) and a net cash position coming from various different US businesses that they have sold.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$57.800
Owned
Yes
TOP PICK
TOP PICK
August 19, 2009
Merging with Merck (MRK-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Merk but this is a discounted way of playing this. (See also MRK-N.)
Merging with Merck (MRK-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Merk but this is a discounted way of playing this. (See also MRK-N.)
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$27.650
Owned
Yes
TOP PICK
TOP PICK
August 19, 2009
Merging with Schering-Plough (SGP-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Schering-Plough, which is a discounted way of playing this. (See also SGP-N.)
Merck & Company (MRK-N)
August 19, 2009
Merging with Schering-Plough (SGP-N). Combination will create a very strong pipeline of products, which for many years will have a good growth profile. It will merge short to mid cycle products with longer-term type products and thinks there are significant synergy type benefits. You could also own Schering-Plough, which is a discounted way of playing this. (See also SGP-N.)
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$31.480
Owned
Yes
TOP PICK
TOP PICK
August 19, 2009
Health supplements. Has been growing through both organic and acquisitions. Has about 13% US market share and are quite strong in Europe. Their intention is to grow to about 20% market share. Attractively priced at about 8X forward earnings.
Health supplements. Has been growing through both organic and acquisitions. Has about 13% US market share and are quite strong in Europe. Their intention is to grow to about 20% market share. Attractively priced at about 8X forward earnings.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$13.770
Owned
Yes
PAST TOP PICK
PAST TOP PICK
August 19, 2009
(A Top Pick July 3/09. Up 7.31%.) Likes the diverse products in their pharmaceutical and medical devices as well as their consumer products area. Still a Buy.
(A Top Pick July 3/09. Up 7.31%.) Likes the diverse products in their pharmaceutical and medical devices as well as their consumer products area. Still a Buy.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$60.370
Owned
Yes
PAST TOP PICK
PAST TOP PICK
August 19, 2009
(A Top Pick July 3/09. Down 6.45%.) Making a number of positive adjustments in their operations and marketing.
(A Top Pick July 3/09. Down 6.45%.) Making a number of positive adjustments in their operations and marketing.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$33.120
Owned
Yes
PAST TOP PICK
PAST TOP PICK
August 19, 2009
(A Top Pick July 3/09. Up 7.81%.) Strong and safe distribution. Attractive assets. Unique asset class and well managed.
(A Top Pick July 3/09. Up 7.81%.) Strong and safe distribution. Attractive assets. Unique asset class and well managed.
Ara Nalbandian
Portfolio Manager, Highwater Capital Management
Price
$16.470
Owned
Yes